One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
Source: NIH
Video » Discover NIMH: Drug Discovery and Development
Published in Psychiatric
More from PsychiatricMore posts in Psychiatric »
- Extramural Research Community Listening Session: Town Hall
- Understanding Psychology's Integrative Themes: Introduction
- The NIMH Director’s Innovation Speaker Series: Addressing Social Determinants to Optimize Infant Brain Development
- Director’s Innovation Speaker Series: Addressing Social Determinants to Optimize Infant Brain Development
- Is it time to rename schizophrenia?